SUBJECTS : Vaccines | Hormones | | Diagnostics | Gene Therapies | Cytolog
Biologics: 2022, vol: 16, issue:
- 1)- Hitomi Kashima, Satohiro Matsumoto, Shu Kojima, Yudai Koito, Takaya Miura, Takehiro Ishii, Hirosato Mashima. Efficacy of Anti-Tumor Necrosis Factor-α Therapy Against Intestinal Behçet's Disease Complicated by Recurrent Enterocutaneous Fistulae. Biologics : targets & therapy. 2022, 16: 1-6
Cited : 2Read More - 2)- Pedro Santos-Moreno, Susan Martinez, Linda Ibata, Laura Villarreal, Fernando Rodríguez-Florido, Manuel Rivero, Adriana Rojas-Villarraga, Claudio Galarza-Maldonado. Is Tofacitinib Effectiveness in Patients with Rheumatoid Arthritis Better After Conventional Than After Biological Therapy? - A Cohort Study in a Colombian Population. Biologics : targets & therapy. 2022, 16: 107-117Cited : 0Read More
- 3)- Nasser M Alorfi, Mansour Marzouq Alourfi. Biologic Therapy for Refractory Immune Checkpoint Inhibitor Colitis. Biologics : targets & therapy. 2022, 16: 119-127Cited : 1Read More
- 4)- Maheeba Abdulla, Nafeesa Mohammed. A Review on Inflammatory Bowel Diseases: Recent Molecular Pathophysiology Advances. Biologics : targets & therapy. 2022, 16: 129-140Cited : 5Read More
- 5)- M Leontien van der Bent, Melvin M Evers, Astrid Vallès. Emerging Therapies for Huntington's Disease - Focus on N-Terminal Huntingtin and Huntingtin Exon 1. Biologics : targets & therapy. 2022, 16: 141-160Cited : 5Read More
- 6)- Radwa Ahmed Batran, Mai Elmoshneb, Ahmed Salah Hussein, Omar M Hussien, Fady Adel, Reham Elgarhy, Mosaad I Morsi. Biosimilars: Science, Implications, and Potential Outlooks in the Middle East and Africa. Biologics : targets & therapy. 2022, 16: 161-171Cited : 5Read More
- 7)- Masayuki Nishide, Mayu Yagita, Atsushi Kumanogoh. Continuous Use of Etanercept During Pregnancy Does Not Affect TNF-Alpha Levels in Umbilical Cord Blood. Biologics : targets & therapy. 2022, 16: 17-19Cited : 0Read More
- 8)- Zigale Hibstu, Habtamu Belew, Yibeltal Akelew, Hylemariam Mihiretie Mengist. Phage Therapy: A Different Approach to Fight Bacterial Infections. Biologics : targets & therapy. 2022, 16: 173-186Cited : 19Read More
- 9)- Jaime Calvo Alén, Bernardo Alio Lavin-Gomez, Elena Aurrecoechea, Armando Raul Guerra Ruiz, Víctor Martínez Taboada, Juan Gómez Gerique. TNF Inhibitors Exert a "Hidden" Beneficial Effect in the Cardiovascular Lipoprotein Profile of RA Patients. Biologics : targets & therapy. 2022, 16: 187-197Cited : 1Read More
- 10)- Pedro Santos-Moreno, Guillermo Sánchez-Vanegas, Angélica Monterrosa-Blanco, Gabriel-Santiago Rodríguez-Vargas, Manuel Rivero, Pedro Rodriguez, Omar-Javier Calixto, Adriana Rojas-Villarraga, Carlos Alberto Castro. Adherence to Subcutaneous Anti-Tumour Necrosis Factor Treatment in a Cohort of Patients with Rheumatoid Arthritis Before and After the Implementation of a Comprehensive Care Model. Biologics : targets & therapy. 2022, 16: 199-209Cited : 1Read More
- 11)- Paola Galozzi, Sara Bindoli, Andrea Doria, Paolo Sfriso. Progress in Biological Therapies for Adult-Onset Still's Disease. Biologics : targets & therapy. 2022, 16: 21-34Cited : 8Read More
- 12)- Yosef Tsegaye Dabi, Henok Andualem, Sisay Teka Degechisa, Solomon Tebeje Gizaw. Targeting Metabolic Reprogramming of T-Cells for Enhanced Anti-Tumor Response. Biologics : targets & therapy. 2022, 16: 35-45Cited : 3Read More
- 13)- Ioannis Mykoniatis, Stavros Tsiakaras, Michael Samarinas, Anastasios Anastasiadis, Evangelos N Symeonidis, Petros Sountoulides. Monoclonal Antibody Therapy for the Treatment of Interstitial Cystitis. Biologics : targets & therapy. 2022, 16: 47-55Cited : 2Read More
- 14)- Valeria Dipasquale, Ugo Cucinotta, Claudio Romano. Biosimilars in Pediatric IBD: Updated Considerations for Disease Management. Biologics : targets & therapy. 2022, 16: 57-66Cited : 2Read More
- 15)- Adam Saleh, Usman Ansari, Shaadi Abughazaleh, Kerri Glassner, Bincy P Abraham. Biological Therapies for the Management of Enteric Disease: Considerations for the Clinician. Biologics : targets & therapy. 2022, 16: 67-83Cited : 0Read More
- 16)- Sally Temraz, Fadi Nasr, Joseph Kattan, Dany Abigerges, Walid Moukadem, Fadi Farhat, Layal Maatouk, Georges Chahine, Ali Shamseddine. A Non-Interventional Multicenter Study of First-Line Bevacizumab in Combination with Chemotherapy in Patients with Metastatic Colorectal Cancer in Lebanon. Biologics : targets & therapy. 2022, 16: 7-15Cited : 0Read More
- 17)- Faisal K Binkhonain, Sara Aldokhayel, Hessah BinJadeed, Abdulaziz Madani. Successful Treatment of an Adult with Atopic Dermatitis and Lamellar Ichthyosis Using Dupilumab. Biologics : targets & therapy. 2022, 16: 85-88Cited : 5Read More
- 18)- Usha Rani Kandula, Addisu Dabi Wake. Promising Stem Cell therapy in the Management of HIV and AIDS: A Narrative Review. Biologics : targets & therapy. 2022, 16: 89-105Cited : 3Read More
